290 related articles for article (PubMed ID: 29475007)
21. In vitro and in situ study on characterization and mechanism of the intestinal absorption of 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside.
Wang C; Zhou Y; Gong X; Zheng L; Li Y
BMC Pharmacol Toxicol; 2020 Jan; 21(1):7. PubMed ID: 31969193
[TBL] [Abstract][Full Text] [Related]
22. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
[TBL] [Abstract][Full Text] [Related]
23. Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine.
Watanabe T; Miyauchi S; Sawada Y; Iga T; Hanano M; Inaba M; Sugiyama Y
J Hepatol; 1992 Sep; 16(1-2):77-88. PubMed ID: 1362433
[TBL] [Abstract][Full Text] [Related]
24. Limited role of P-glycoprotein in the intestinal absorption of cyclosporin A.
Lee YJ; Chung SJ; Shim CK
Biol Pharm Bull; 2005 Apr; 28(4):760-3. PubMed ID: 15802827
[TBL] [Abstract][Full Text] [Related]
25. Regional difference in P-glycoprotein function in rat intestine.
Iida A; Tomita M; Hayashi M
Drug Metab Pharmacokinet; 2005 Apr; 20(2):100-6. PubMed ID: 15855720
[TBL] [Abstract][Full Text] [Related]
26. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
Dahan A; Amidon GL
Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
[TBL] [Abstract][Full Text] [Related]
27. In Vitro and In Situ Characterization of the Intestinal Absorption of Capilliposide B and Capilliposide C from
Zhang X; Cheng X; Wu Y; Feng D; Qian Y; Chen L; Yang B; Gu M
Molecules; 2019 Mar; 24(7):. PubMed ID: 30925820
[TBL] [Abstract][Full Text] [Related]
28. Baicalin reduces ciclosporin bioavailability by inducing intestinal p-glycoprotein in rats.
Tian X; Chang Y; Wei J; Liu R; Wang L; Zhang J; Zhang X
J Pharm Pharmacol; 2019 May; 71(5):788-796. PubMed ID: 30663770
[TBL] [Abstract][Full Text] [Related]
29. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4.
Cummins CL; Jacobsen W; Benet LZ
J Pharmacol Exp Ther; 2002 Mar; 300(3):1036-45. PubMed ID: 11861813
[TBL] [Abstract][Full Text] [Related]
30. P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug-herb/drug-drug interactions.
Liang S; Deng F; Xing H; Wen H; Shi X; Martey ON; Koomson E; He X
Drug Des Devel Ther; 2014; 8():475-83. PubMed ID: 24872678
[TBL] [Abstract][Full Text] [Related]
31. Acetaminophen inhibits intestinal p-glycoprotein transport activity.
Novak A; Carpini GD; Ruiz ML; Luquita MG; Rubio MC; Mottino AD; Ghanem CI
J Pharm Sci; 2013 Oct; 102(10):3830-7. PubMed ID: 23897240
[TBL] [Abstract][Full Text] [Related]
32. Comparative effects on intestinal absorption in situ by P-glycoprotein-modifying HIV protease inhibitors.
Richter M; Gyémánt N; Molnár J; Hilgeroth A
Pharm Res; 2004 Oct; 21(10):1862-6. PubMed ID: 15553233
[TBL] [Abstract][Full Text] [Related]
33. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
34. [Transport of limonin in rat intestine in situ and Caco-2 cells in vitro].
Zhang XY; Ke X; He L; Tian JL
Yao Xue Xue Bao; 2012 Feb; 47(2):229-32. PubMed ID: 22512036
[TBL] [Abstract][Full Text] [Related]
35. Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretion.
Yue W; Abe K; Brouwer KL
Mol Pharm; 2009; 6(1):134-43. PubMed ID: 19105722
[TBL] [Abstract][Full Text] [Related]
36. Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro.
Zhao YY; Fan Y; Wang M; Wang J; Cheng JX; Zou JB; Zhang XF; Shi YJ; Guo DY
Biomed Pharmacother; 2020 Dec; 132():110809. PubMed ID: 33049584
[TBL] [Abstract][Full Text] [Related]
37. Organic Anion-Transporting Polypeptide and Efflux Transporter-Mediated Hepatic Uptake and Biliary Excretion of Cilostazol and Its Metabolites in Rats and Humans.
Wang C; Huo X; Wang C; Meng Q; Liu Z; Sun P; Cang J; Sun H; Liu K
J Pharm Sci; 2017 Sep; 106(9):2515-2523. PubMed ID: 28535976
[TBL] [Abstract][Full Text] [Related]
38. Reversible inhibition of efflux transporters by hydrogel microdevices.
Levy ES; Samy KE; Lamson NG; Whitehead KA; Kroetz DL; Desai TA
Eur J Pharm Biopharm; 2019 Dec; 145():76-84. PubMed ID: 31639417
[TBL] [Abstract][Full Text] [Related]
39. Excretion of the dipeptidyl peptidase-4 inhibitor linagliptin in rats is primarily by biliary excretion and P-gp-mediated efflux.
Fuchs H; Runge F; Held HD
Eur J Pharm Sci; 2012 Apr; 45(5):533-8. PubMed ID: 22198311
[TBL] [Abstract][Full Text] [Related]
40. P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide.
Hoffmaster KA; Turncliff RZ; LeCluyse EL; Kim RB; Meier PJ; Brouwer KL
Pharm Res; 2004 Jul; 21(7):1294-302. PubMed ID: 15290872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
